HIV & AIDS

First new HIV vaccine efficacy study in seven years has begun

The first HIV vaccine efficacy study to launch anywhere in seven years is now testing whether an experimental vaccine regimen safely prevents HIV infection among South African adults. The study, called HVTN 702, involves ...

Obstetrics & gynaecology

Women's wellness: vaginal yeast infections

A vaginal yeast infection is a fungal infection that causes irritation, discharge and intense itchiness of the vagina and the vulva - the tissues at the vaginal opening. It's a type of vaginitis, or inflammation of the vagina. ...

HIV & AIDS

Genetically engineered T cells render HIV's harpoon powerless

When HIV attacks a T cell, it attaches itself to the cell's surface and launches a "harpoon" to create an opening to enter and infect the cells. To stop the invasion, researchers from the Penn Center for AIDS Research at ...

HIV & AIDS

HIV survives in our chromosomal DNA

It has been said that HIV cannot be cured since the virus propagates in places beyond the reach of antiviral agents. New research from Karolinska Institutet suggests, however, that this view is incorrect.

HIV & AIDS

Researchers use CRISPR to accelerate search for HIV cure

Researchers at UC San Francisco and the academically affiliated Gladstone Institutes have used a newly developed gene-editing system to find gene mutations that make human immune cells resistant to HIV infection.

page 40 from 40